| Financial Year |
March 31 2023 |
| Monetary Funds |
938,300,597.76 |
| Held-for-trading Financial Assets |
116,314,742.09 |
| Notes Receivable |
18,983,840.76 |
| Accounts Receivable |
377,404,912.65 |
| Advances to Suppliers |
28,542,588.53 |
| Other Receivables |
14,572,845.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
690,998,613.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
26,680,253.41 |
| Total Current Assets |
2,213,369,084.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
66,578,428.91 |
| Investment Properties |
-- |
| Fixed Assetes |
1,096,415,315.12 |
| Under-construction Projects |
185,651,375.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
294,431,719.42 |
| R&D expenses |
48,543.69 |
| Goodwill |
471,389,324.78 |
| Long-Term Deferred and Prepaid Expenses |
46,800,407.83 |
| Deferred Income Tax Assets |
164,669,490.80 |
| Other Non-Current Assets |
4,875,189.81 |
| Sub-Total of Non-Current Assets |
3,212,365,822.55 |
| Total Assets |
5,425,734,906.58 |
| Short-Term Loans |
66,961,515.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
34,034,293.07 |
| Accounts Payable |
169,357,015.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
27,881,347.48 |
| Taxes Payable |
29,306,182.78 |
| Interest Payable |
-- |
| Dividend Payable |
46,494.45 |
| Other payables |
25,127,449.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
466,140,266.41 |
| Other Current Liabilities |
18,185,481.88 |
| Sub-Total of Current Liabilities |
842,105,861.06 |
| Long-term Loans |
413,036,978.89 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,372,732.57 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
155,657,433.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
863,604,508.92 |
| Total Liabilities |
1,705,710,369.98 |
| Paid-In Capital(Or Share Stock) |
609,934,771.00 |
| Capital Surplus |
791,803,407.49 |
| Surplus Reserve |
308,240,963.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,063,963,171.26 |
| Minority Stockholder's Interest |
8,326,279.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,711,698,257.09 |
| Owner's Equity（Stockholder's Equity） |
3,720,024,536.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,425,734,906.58 |
